Palisade Bio Ownership | Who Owns Palisade Bio?

Palisade Bio Ownership Summary

Palisade Bio is owned by 276.14% institutional investors, 0.03% insiders. Franklin resources is the largest institutional shareholder, holding 68.14% of PALI shares. Franklin Biotechnology Discv A(acc)USD is the top mutual fund, with 2.19% of its assets in Palisade Bio shares.

PALI Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Palisade Bio	276.14%	0.03%	-176.18%
Sector	Healthcare Stocks	232.86%	10.65%	-143.51%
Industry	Biotech Stocks	382.13%	10.41%	-292.54%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Franklin resources	5.09M	68.14%	$11.97M
Renaissance	2.38M	31.88%	$5.60M
Vivo capital	2.29M	30.69%	$5.39M
Vanguard group	2.12M	28.31%	$4.97M
Blackrock funding, inc. /de	1.88M	25.15%	$4.42M
Geode capital management	1.57M	20.95%	$3.68M
Exome asset management	758.20K	10.14%	$1.78M
Platinum investment management	664.09K	8.89%	$1.56M
Hudson bay capital management lp	656.46K	8.78%	$1.54M
Goldman sachs group	557.57K	7.46%	$1.31M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Exome asset management	758.20K	0.85%	$1.78M
Platinum investment management	664.09K	0.36%	$1.56M
Act capital management	257.50K	0.35%	$450.63K
Vivo capital	2.29M	0.35%	$5.39M
Caitong asset management	29.39K	0.19%	$69.06K
Virtus etf advisers	46.00K	0.05%	$108.10K
Silverarc capital management	102.11K	0.03%	$239.95K
Bit capital gmbh	305.00K	0.03%	$716.75K
Pale fire capital se	70.71K	0.01%	$166.17K
Total clarity wealth management	27.00K	0.01%	$47.25K

Top Buyers

Holder	Shares	% Assets	Change
Franklin resources	5.09M	0.00%	5.09M
Renaissance	2.38M	0.01%	2.38M
Vivo capital	2.29M	0.35%	2.29M
Vanguard group	2.12M	0.00%	2.12M
Blackrock funding, inc. /de	1.88M	0.00%	1.88M

Top Sellers

Holder	Shares	% Assets	Change
Jefferies financial group	34.88K	0.00%	-11.89K
Total clarity wealth management	27.00K	0.01%	-2.94K
Avion wealth	-	-	-500.00
Commonwealth equity services	16.50K	-	-150.00
Federation des caisses desjardins du quebec	100.00	-	-

New Positions

Holder	Shares	% Assets	Change	Value
Franklin resources	5.09M	0.00%	5.09M	$11.97M
Renaissance	2.38M	0.01%	2.38M	$5.60M
Vivo capital	2.29M	0.35%	2.29M	$5.39M
Vanguard group	2.12M	0.00%	2.12M	$4.97M
Blackrock funding, inc. /de	1.88M	0.00%	1.88M	$4.42M

Sold Out

Holder	Change
Avion wealth	-500.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Dec 31, 2025	35	191.67%	20,638,757	17157.64%	276	10785.35%	33	266.67%	-	-100.00%
Sep 30, 2025	12	9.09%	119,592	41.34%	1	51.44%	9	80.00%	1	-66.67%
Jun 30, 2025	11	-	84,610	-67.53%	1	5.97%	5	-37.50%	3	200.00%
Mar 31, 2025	11	22.22%	260,593	30.80%	5	2.75%	8	33.33%	1	-
Dec 31, 2024	9	12.50%	199,223	220.82%	14	73.15%	6	50.00%	1	-

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Franklin Biotechnology Discv A(acc)USD	3.66M	2.19%	-107.37K
Federated Hermes Kaufmann Small Cap Grow	3.14M	1.87%	3.14M
Federated Hermes Kaufmann Small Cap A	3.14M	1.87%	3.14M
Biotech Growth Ord	2.33M	1.39%	461.58K
Franklin Biotechnology Discovery A	2.12M	1.26%	-
Vanguard Institutional Extnd Mkt Idx Tr	1.43M	0.85%	45.27K
Fidelity Extended Market Index	690.58K	0.41%	12.41K
abrdn Life Sciences Investors	662.90K	0.40%	662.90K
Truvalue Glb Phrmctl Blgcl Eq (QDII) A	548.12K	0.33%	548.12K
Simplify Propel Opportunities ETF	532.52K	0.32%	-

Recent Insider Transactions

Date	Name	Role	Activity	Value
Feb 12, 2026	Jones Mitchell Lawrence	Chief Medical Officer	Sell	$3.48K
Feb 12, 2026	Finley John David	CEO, CFO	Sell	$6.82K
Jan 16, 2026	Williams Donald Allen	-	Buy	$8.36K
Jan 09, 2026	Williams Donald Allen	-	Buy	$9.40K
May 28, 2024	Williams Donald Allen	-	Buy	$4.86K

Insider Transactions Trends

Date	Buy	Sell
2026 Q1	2	2
2025 Q4	-	-
2025 Q3	-	-
2025 Q1	-	-
2024 Q4	-	-

PALI Ownership FAQ

Who Owns Palisade Bio?

Palisade Bio shareholders are primarily institutional investors at 276.14%, followed by 0.03% insiders and -176.17% retail investors. The average institutional ownership in Palisade Bio's industry, Biotech Stocks , is 382.13%, which Palisade Bio falls below.

Who owns the most shares of Palisade Bio?

Palisade Bio’s largest shareholders are Franklin resources (5.09M shares, 68.14%), Renaissance (2.38M shares, 31.88%), and Vivo capital (2.29M shares, 30.69%). Together, they hold 130.70% of Palisade Bio’s total shares outstanding.

Does Blackrock own Palisade Bio?

BlackRock is not among the top 10 institutional shareholders of Palisade Bio.

Who is Palisade Bio’s biggest shareholder by percentage of total assets invested?

Exome asset management is Palisade Bio’s biggest shareholder by percentage of total assets invested, with 0.85% of its assets in 758.2K Palisade Bio shares, valued at 1.78M$.

Who is the top mutual fund holder of Palisade Bio shares?

Franklin Biotechnology Discv A(acc)USD is the top mutual fund holder of Palisade Bio shares, with 2.19% of its total shares outstanding invested in 3.66M Palisade Bio shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools